| scholarly article | Q13442814 |
| P50 | author | Oliver Fiehn | Q28540892 |
| P2093 | author name string | Hala El-Said | |
| Ashraf Elfert | |||
| Ibrahim Salama | |||
| Israa T Ismail | |||
| Marwa Helal | |||
| P2860 | cites work | Diagnosis of hepatocellular carcinoma | Q80850379 |
| Highly sensitive alpha-fetoprotein, Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxyprothrombin for hepatocellular carcinoma detection | Q85393270 | ||
| Urinary metabolic profiling identifies a key role for glycocholic acid in human liver cancer by ultra-performance liquid-chromatography coupled with high-definition mass spectrometry | Q85892016 | ||
| Correlation between biological marker expression and fluorine-18 fluorodeoxyglucose uptake in hepatocellular carcinoma | Q87581767 | ||
| Redox imbalance stress in diabetes mellitus: Role of the polyol pathway | Q88970936 | ||
| When fats commit crimes: fatty acid metabolism, cancer stemness and therapeutic resistance | Q89573138 | ||
| Uric acid activates aldose reductase and the polyol pathway for endogenous fructose and fat production causing development of fatty liver in rats | Q91080329 | ||
| Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease/steatohepatitis and liver transplantation | Q91244634 | ||
| Role of Gut Microbiota in Hepatocarcinogenesis | Q91796502 | ||
| Disease Burden of Hepatocellular Carcinoma: A Global Perspective | Q92136309 | ||
| Sugar alcohol provides imaging contrast in cancer detection | Q92321696 | ||
| Metabolomics profiles of patients with Wilson disease reveal a distinct metabolic signature | Q92346246 | ||
| Quercetin Inhibits the Proliferation of Glycolysis-Addicted HCC Cells by Reducing Hexokinase 2 and Akt-mTOR Pathway | Q92349557 | ||
| Genetic variation in microRNA-100 (miR-100) rs1834306 T/C associated with Hepatitis B virus (HBV) infection: Correlation with expression level | Q92600949 | ||
| Metabolomic Analysis of Liver Tissues for Characterization of Hepatocellular Carcinoma | Q92678692 | ||
| The Epidemiology of Hepatocellular Carcinoma in the USA | Q93047633 | ||
| Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013 | Q93068104 | ||
| Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma | Q93108729 | ||
| Identification and Characterization of a Novel Human Aldose Reductase-like Gene | Q24310650 | ||
| KEGG Atlas mapping for global analysis of metabolic pathways | Q24646257 | ||
| Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances | Q26745338 | ||
| Hepatocellular Carcinoma: Risk Factors, Diagnosis and Treatment | Q26747551 | ||
| Regulation of glucose metabolism from a liver-centric perspective | Q26766488 | ||
| Gut Microbiota and Hepatocellular Carcinoma | Q26775568 | ||
| Epidemiology of hepatocellular carcinoma in sub-Saharan Africa | Q27008900 | ||
| FiehnLib: Mass Spectral and Retention Index Libraries for Metabolomics Based on Quadrupole and Time-of-Flight Gas Chromatography/Mass Spectrometry | Q27807494 | ||
| Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects | Q28076454 | ||
| Guide for diagnosis and treatment of hepatocellular carcinoma | Q28084003 | ||
| All in the family: aldose reductase and closely related aldo-keto reductases | Q28257368 | ||
| THE METABOLISM OF TUMORS IN THE BODY | Q29616202 | ||
| The pathobiology of diabetic complications: a unifying mechanism | Q29617766 | ||
| Screening for hepatocellular carcinoma: patient selection and perspectives | Q30355713 | ||
| Inhibition of aldose reductase prevents colon cancer metastasis | Q30503931 | ||
| Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis | Q33287430 | ||
| Sorbitol dehydrogenase overexpression and other aspects of dysregulated protein expression in human precancerous colorectal neoplasms: a quantitative proteomics study. | Q33583152 | ||
| Hepatitis C infection in Egypt: prevalence, impact and management strategies | Q33713718 | ||
| Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? | Q33917658 | ||
| Sparse PLS discriminant analysis: biologically relevant feature selection and graphical displays for multiclass problems | Q33938692 | ||
| Hepatocellular carcinoma in the world and the middle East | Q34134967 | ||
| Molecular pathogenesis of human hepatocellular carcinoma. | Q34167480 | ||
| Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS. | Q34214476 | ||
| Aldose metabolism in developing human fetal brain and liver | Q34260484 | ||
| New member of aldose reductase family proteins overexpressed in human hepatocellular carcinoma | Q34463575 | ||
| Regulation of glucose metabolism in hepatocarcinogenesis by microRNAs | Q34803043 | ||
| Serum and Urine Metabolite Profiling Reveals Potential Biomarkers of Human Hepatocellular Carcinoma | Q35098539 | ||
| Targeting aldose reductase for the treatment of cancer | Q35125587 | ||
| Contribution of polyol pathway to diabetes-induced oxidative stress | Q35182353 | ||
| Identification of Serum Proton NMR Metabolomic Fingerprints Associated with Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis | Q61764152 | ||
| MetaboAnalystR 2.0: From Raw Spectra to Biological Insights | Q64062848 | ||
| Efficacy of aldose reductase inhibitors is affected by oxidative stress induced under X-ray irradiation | Q64092883 | ||
| The Diverse Functions of Non-Essential Amino Acids in Cancer. | Q64971598 | ||
| Elevation of aldose reductase gene expression in rat primary hepatoma and hepatoma cell lines: implication in detoxification of cytotoxic aldehydes | Q71740598 | ||
| Identification of tumor-associated protein variants during rat hepatocarcinogenesis. Aldose reductase | Q72417374 | ||
| Race-ethnicity-specific variation in multiple-marker biochemical screening: alpha-fetoprotein, hCG, and estriol | Q73114804 | ||
| Overexpression of aldose reductase in human cancer tissues | Q79394292 | ||
| Metabolomic Characterization of Hepatocellular Carcinoma in Patients with Liver Cirrhosis for Biomarker Discovery | Q50540296 | ||
| Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma | Q52355121 | ||
| Deciphering hepatocellular carcinoma through metabolomics: from biomarker discovery to therapy evaluation. | Q52564715 | ||
| Epidemiology of liver cancer in Nile delta over a decade: A single-center study. | Q53697334 | ||
| Aldose reductase inhibitor protects mice from alcoholic steatosis by repressing saturated fatty acid biosynthesis | Q54239382 | ||
| Immunodetection of aldose reductase in normal and diseased human liver | Q54678238 | ||
| Induction of aldose reductase gene expression in LEC rats during the development of the hereditary hepatitis and hepatoma. | Q55162366 | ||
| Aspartate is an endogenous metabolic limitation for tumour growth | Q57095796 | ||
| Evaluation of Diagnostic Efficiency of Alpha-Fetoprotein in Patients with Liver Cirrhosis and Hepatocellular Carcinoma: Single-Center Experience | Q58552332 | ||
| Perioperative serum and urine metabolome analyses in patients with hepatocellular carcinoma undergoing partial hepatectomy | Q58566032 | ||
| A Comprehensive Untargeted Metabonomic Analysis of Human Steatotic Liver Tissue by RP and HILIC Chromatography Coupled to Mass Spectrometry Reveals Important Metabolic Alterations | Q58680836 | ||
| High Expression of Glycolytic Genes in Cirrhosis Correlates With the Risk of Developing Liver Cancer | Q59133582 | ||
| Update in global trends and aetiology of hepatocellular carcinoma | Q59136659 | ||
| Lipid Metabolic Reprogramming in Hepatocellular Carcinoma | Q59800592 | ||
| Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries | Q60142201 | ||
| Characterization of heterogeneous redox responses in hepatocellular carcinoma patients using network analysis. | Q61445631 | ||
| Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling | Q35501184 | ||
| GC-MS Based Plasma Metabolomics for Identification of Candidate Biomarkers for Hepatocellular Carcinoma in Egyptian Cohort | Q35648370 | ||
| Whole Blood Reveals More Metabolic Detail of the Human Metabolome than Serum as Measured by 1H-NMR Spectroscopy: Implications for Sepsis Metabolomics. | Q35957668 | ||
| Metabolomics by Gas Chromatography-Mass Spectrometry: Combined Targeted and Untargeted Profiling | Q35977700 | ||
| Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis | Q36165635 | ||
| Chromatographic determination of some biomarkers of liver cirrhosis and hepatocellular carcinoma in Egyptian patients. | Q36197829 | ||
| Serum Metabolomics to Identify the Liver Disease-Specific Biomarkers for the Progression of Hepatitis to Hepatocellular Carcinoma | Q36360941 | ||
| The Emerging Hallmarks of Cancer Metabolism | Q36468964 | ||
| Detection of polyol accumulation in a new ovarian carcinoma cell line, CABA I: a(1)H NMR study | Q36623925 | ||
| Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes. | Q36788477 | ||
| Epidemiology of hepatocellular carcinoma: consider the population | Q36930514 | ||
| Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification. | Q36961679 | ||
| Cellular fatty acid metabolism and cancer | Q37092913 | ||
| Aldose reductase: a novel therapeutic target for inflammatory pathologies. | Q37455375 | ||
| Evaluation of metabolite biomarkers for hepatocellular carcinoma through stratified analysis by gender, race, and alcoholic cirrhosis | Q37625766 | ||
| Factors that affect accuracy of α-fetoprotein test in detection of hepatocellular carcinoma in patients with cirrhosis | Q37684651 | ||
| Diabetic cataracts: mechanisms and management | Q37754161 | ||
| The etiology of hepatocellular carcinoma and consequences for treatment | Q37813313 | ||
| Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma. | Q38540380 | ||
| Nuclear magnetic resonance metabolomics and human liver diseases: The principles and evidence associated with protein and carbohydrate metabolism. | Q38834940 | ||
| Regulation of hepatic glucose metabolism in health and disease | Q39450184 | ||
| BCAT1, a key prognostic predictor of hepatocellular carcinoma, promotes cell proliferation and induces chemoresistance to cisplatin. | Q39721204 | ||
| GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis | Q39872802 | ||
| Diagnostic delays are common among patients with hepatocellular carcinoma | Q40279432 | ||
| Metabolomics and eicosanoid analysis identified serum biomarkers for distinguishing hepatocellular carcinoma from hepatitis B virus-related cirrhosis | Q41926352 | ||
| Aldose reductase interacts with AKT1 to augment hepatic AKT/mTOR signaling and promote hepatocarcinogenesis | Q42366521 | ||
| The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma. | Q42373936 | ||
| Polyol accumulation in muscle and liver in a mouse model of type 2 diabetes | Q42414753 | ||
| Elevated serum testosterone levels and risk of hepatocellular carcinoma | Q43048451 | ||
| Overexpression of aldose reductase in liver cancers may contribute to drug resistance | Q43549654 | ||
| Inhibition of aldose reductase enhances HeLa cell sensitivity to chemotherapeutic drugs and involves activation of extracellular signal-regulated kinases | Q44190175 | ||
| Aldose reductase regulates hepatic peroxisome proliferator-activated receptor alpha phosphorylation and activity to impact lipid homeostasis. | Q46003997 | ||
| Branched-chain amino acid metabolism in cancer | Q46301158 | ||
| Identifying metabolites by integrating metabolome databases with mass spectrometry cheminformatics. | Q46695013 | ||
| Chemical Similarity Enrichment Analysis (ChemRICH) as alternative to biochemical pathway mapping for metabolomic datasets | Q46961388 | ||
| Detection of hepatitis C virus (HCV) among health care providers in an Egyptian university hospital: different diagnostic modalities | Q47130766 | ||
| Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide. | Q47547281 | ||
| Aberrant Lipid Metabolism in Hepatocellular Carcinoma Revealed by Liver Lipidomics | Q49575221 | ||
| Polyol pathway links glucose metabolism to the aggressiveness of cancer cells | Q49990358 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| chronic liver disease | Q5113984 | ||
| whole blood | Q7997549 | ||
| P577 | publication date | 2020-02-19 | |
| P1433 | published in | Cancers | Q27722963 |
| P1476 | title | Sugar Alcohols Have a Key Role in Pathogenesis of Chronic Liver Disease and Hepatocellular Carcinoma in Whole Blood and Liver Tissues | |
| P478 | volume | 12 |
Search more.